Live recombinant vector vaccines for veterinary use - Scientific guideline

Scientific guidelineVeterinaryScientific guidelines

Norwegian is available via eTranslation, the European Commission's machine translation service.

Translate to Norwegian | Important information about machine translation

This guidelines provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Keywords: Live, recombinant vector vaccine, veterinary

Current version

Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Adopted Reference Number: EMA/CVMP/IWP/390313/2023 Legal effective date:

English (EN) (224.05 KB - PDF)

Først publisert:
Vis

Revision 1

Draft guideline on live recombinant vector vaccines for veterinary use - Revision 1

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/IWP/390313/2023 Summary:

This guideline provides guidance on the data to be submitted in the marketing authorisation application for the veterinary live recombinant vector vaccines. 

Comments should be provided using this template. The completed comments form should be sent IWP@ema.europa.eu

English (EN) (236.82 KB - PDF)

Først publisert:
Vis

Overview of comments received on Guideline on live recombinant vector vaccines for veterinary use - Revision 1

Reference Number: EMA/260063/2024

English (EN) (174.68 KB - PDF)

Først publisert:
Vis

First version

Guideline on live recombinant vector vaccines for veterinary use

Adopted Reference Number: EMEA/CVMP/004/04-FINAL Legal effective date:

English (EN) (49.66 KB - PDF)

Først publisert: Sist oppdatert:
Vis

Concept paper for the revision of the guideline on live recombinant vector vaccines for veterinary use

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/IWP/161133/2023

English (EN) (158.52 KB - PDF)

Først publisert:
Vis

Share this page